RXRA and nephrolithiasis: Tubular‐specific deletion of RXRα increased intrarenal CaOx crystal deposition, while its activation with Bexarotene suppressed this process by reprogramming enhancer profiles and downregulating nephrolithiasis‐promoting genes.